{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:42:35Z","timestamp":1762144955012},"reference-count":60,"publisher":"American Society of Consultant Pharmacists","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.4140\/tcp.n.2013.443","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T01:04:57Z","timestamp":1373331897000},"page":"443-454","source":"Crossref","is-referenced-by-count":7,"title":["A Paradigm Shift for Evaluating Pharmacotherapy for Alzheimer's Disease: The 10-Patient Screening Protocol"],"prefix":"10.4140","volume":"28","author":[{"given":"James D.","family":"Weinstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar R.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Egleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2013,7,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archneurol.2011.70","article-title":"Amyloid dependent and amyloid-independent stages of Alzheimer's disease","volume":"68","author":"BT Hyman","year":"2011","journal-title":"Arch Neuro"},{"key":"2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer's disease","volume":"63","author":"RH Swerdlow","year":"2004","journal-title":"Med Hypothesis"},{"key":"3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.18632\/aging.100088","article-title":"Mitochondrial superoxide: a key player in Alzheimer's disease","volume":"9","author":"CA Massaad","year":"2009","journal-title":"Aging"},{"key":"4","doi-asserted-by":"crossref","first-page":"16504","DOI":"10.1074\/jbc.M110.208447","article-title":"Alternative mitochondrial electron transfer as a novel strategy for neuroprotection","volume":"286","author":"Y Wen","year":"2011","journal-title":"J Biol Chem"},{"key":"5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.jnen.0000228136.58062.bf","article-title":"Involvement of oxidative stress in Alzheimer's disease","volume":"65","author":"A Nunomura","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"6","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1046\/j.1432-1327.2000.01595.x","article-title":"Glutathione, oxidative stress and neurodegeneration","volume":"267","author":"JB Schulz","year":"2000","journal-title":"Eur J Biochem"},{"key":"7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","article-title":"Advances in metal-induced oxidative stress and human disease","volume":"283","author":"K Jomova","year":"2011","journal-title":"Toxicol"},{"issue":"Suppl 3","key":"8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/PL00014177","article-title":"Investigations on oxidative stress and therapeutical implications in dementia","volume":"249","author":"N Durany","year":"1999","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","article-title":"Activated astroglia during chronic inflammation in Alzheimer's disease - do they neglect their neurosupportive roles?","volume":"690","author":"S Fuller","year":"2010","journal-title":"Mutat Res"},{"key":"10","first-page":"11213","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease","volume":"93","author":"RW Mahley","year":"1996","journal-title":"Proc Nat Acad Sci"},{"key":"11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"235","author":"P Kramer","year":"2012","journal-title":"Science"},{"key":"12","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer's disease-like tau aggregation by phenothiazines","volume":"93","author":"CM Wishik","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-2008-13403","article-title":"Chlamydophila pneumoniae and the etiology of late onset Alzheimer's disease","volume":"13","author":"BJ Balin","year":"2008","journal-title":"J Alzheimer Dis"},{"key":"14","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse formation and function is modulated by the amyloid precursor protein","volume":"26","author":"C Priller","year":"2006","journal-title":"J Neurosci"},{"key":"15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","article-title":"Expression of APP pathway mRNAs and proteins in Alzheimer's disease","volume":"1161","author":"T Matsui","year":"2007","journal-title":"Brain Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"A Goate","year":"1991","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1925564","article-title":"A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease","volume":"254","author":"J Murrell","year":"1991","journal-title":"Science"},{"key":"18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/353844a0","article-title":"Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene","volume":"353","author":"MC Chartier-Harlin","year":"1991","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"M Citron","year":"1992","journal-title":"Nature"},{"key":"20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0798-827","article-title":"Aging renders the brain vulnerable to amyloid B-protein neurotoxicity","volume":"4","author":"C Guela","year":"1998","journal-title":"Nat Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neurobiolaging.2007.01.009","article-title":"Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells","volume":"29","author":"M Coma","year":"2008","journal-title":"Neurobiol Aging"},{"key":"22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12017-011-8155-9","article-title":"Oxidative stress and beta-amyloid protein in Alzheimer's disease","volume":"13","author":"Z Cai","year":"2011","journal-title":"Neuromol Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-009-0568-7","article-title":"D-amyloid oligomers and cellular prion protein in Alzheimer's disease","volume":"88","author":"EC Gunther","year":"2010","journal-title":"J Mol Med"},{"key":"24","first-page":"2566","article-title":"Beta-amyloid stimulated microglia induced neuron death via synergistic stimulation of tumor necrosis factor A and NMDA receptors","volume":"25","author":"AM Floden","year":"2005","journal-title":"J Neuro Sci"},{"issue":"9","key":"25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of AB accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"M Manczak","year":"2006","journal-title":"Human Molec Genet"},{"key":"26","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction","volume":"26","author":"L Devi","year":"2006","journal-title":"J Neurosci"},{"key":"27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","article-title":"Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease","volume":"96","author":"PH Reddy","year":"2006","journal-title":"J Neurochem"},{"key":"28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/ph3010158","article-title":"Oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of Alzheimer's disease","volume":"3","author":"G Alive","year":"2010","journal-title":"Pharmaceuticals"},{"key":"29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11597760-000000000-00000","article-title":"Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease","volume":"72","author":"SM De la Monte","year":"2012","journal-title":"Drugs"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/683728","article-title":"Oxidative toxicity in neurodegenerative disease; role of mitochondrial dysfunction and therapeutic strategies","author":"K Facecchia","year":"2011","journal-title":"J Toxicol"},{"issue":"Suppl 2","key":"31","article-title":"Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury","volume":"20","author":"GC Higgins","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/156720507779939788","article-title":"Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease","volume":"4","author":"Q Ding","year":"2007","journal-title":"Curr Alzheimer Res Feb"},{"key":"33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/CCLM.2011.079","article-title":"Advanced glycation endproducts as gerontoxins and biomarkers for carbonyl based degenerative processes in Alzheimer's disease","volume":"49","author":"A Rahmadi","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-3-7091-6139-5_28","article-title":"Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease - a target for neuroprotective treatment strategies?","volume":"62","author":"G Munch","year":"2002","journal-title":"J Neuro Transm Suppl"},{"key":"35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/glia.20678","article-title":"Microglial dystrophy in the aged Alzheimer's disease brain is associated with ferritin aminoreactivity","volume":"56","author":"KO Lopes","year":"2008","journal-title":"Glia"},{"key":"36","first-page":"165","article-title":"Oxidative modification of ferritin induced by hydrogen peroxide","volume":"44","author":"J Yoon","year":"2011","journal-title":"Biochem Mol Bio Reports"},{"key":"37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","article-title":"Activated astroglia during chronic inflammation in Alzheimer's disease - do they neglect their neurosupportive roles?","volume":"690","author":"S Fuller","year":"2010","journal-title":"Mutat Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease","volume":"118","author":"WJ Streit","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"9","key":"39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00044011-200828090-00001","article-title":"Therapeutic use of nicergoline","volume":"28","author":"B Winblad","year":"2008","journal-title":"Clin Drug Invest"},{"key":"40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/nu3080735","article-title":"Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose oxygen pyruvate, creatine, and l-carnitine","volume":"3","author":"L Owen","year":"2011","journal-title":"Nutrients"},{"key":"41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.406.1\/2011\/820903","article-title":"Therapeutic approaches to delay the onset of Alzheimer's disease","volume":"1","author":"R Kumar","year":"2011","journal-title":"J Aging Res"},{"key":"42","article-title":"Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease","volume":"467","author":"G He","year":"2010","journal-title":"Nature"},{"key":"43","article-title":"Therapeutic potential of resveratrol in Alzheimer's disease","volume":"9","author":"V Vingtdeux","year":"2008","journal-title":"BNC Neuro Sci"},{"key":"44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pharmthera.2006.07.001","article-title":"Lipoic acid as a novel treatment for Alzheimer's disease and related dementias","volume":"113","author":"L Holmquist","year":"2007","journal-title":"Pharmacol Ther"},{"key":"45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-60327-029-8_8","article-title":"Nanopartical and iron chelators as a potential novel Alzheimer's therapy","volume":"610","author":"G Liu","year":"2010","journal-title":"Methods Mol Biol"},{"key":"46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1010052800347","article-title":"AGEs in brain aging: AGE inhibitors as neuroprotective and antidementia drugs","volume":"2","author":"SD Stefanovic","year":"2001","journal-title":"Biogerentology"},{"key":"47","doi-asserted-by":"crossref","DOI":"10.1093\/ajcn\/83.2.470S","article-title":"Inflammation and neurodegenerative diseases","volume":"83","author":"WS Griffin","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jalz.2009.07.038","article-title":"Current Alzheimer's disease clinical trials: methods and placebo outcomes","volume":"5","author":"LS Schneider","year":"2009","journal-title":"Alzheimer Dement"},{"key":"49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000054762","article-title":"Combination therapies and the theoretical limits of evidence-based medicine","volume":"10","author":"JL Saver","year":"2001","journal-title":"Neuroepidemiol"},{"key":"50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WAD.0b013e318194a324","article-title":"Rate of decline in Alzheimer's disease measured by dementia severity rating scale","volume":"23","author":"SX Xie","year":"2009","journal-title":"Alzheimers Dis Assoc Disord"},{"key":"51","first-page":"639","article-title":"Clinical dementia rating (CDR)","volume":"25","author":"L Berg","year":"1988","journal-title":"Psychopharmacol Bull"},{"issue":"Suppl 2","key":"52","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease","volume":"11","author":"D Galasko","year":"1997","journal-title":"Alzheimer's Dis Assoc Disord"},{"key":"53","first-page":"31","article-title":"Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer's disease","volume":"10","author":"CM Clark","year":"1996","journal-title":"Alzheimers Dis Assoc Disord"},{"key":"54","first-page":"321","article-title":"Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients? A longitudinal analysis","volume":"7","author":"CG Iopen","year":"1999","journal-title":"Am J Geriatr Psychiatry"},{"key":"55","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1365-2389.2003.51276.x","article-title":"The value of informant reports for the assessment and prediction of dementia","volume":"51","author":"AF Jorn","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"56","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1393::AID-SIM431>3.0.CO;2-O","article-title":"Measurement of progression in Alzheimer's disease: a clinician's perspective","volume":"19","author":"DJ Gelb","year":"2000","journal-title":"Stat Med"},{"key":"57","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410160605","article-title":"Cortical abnormalities in Alzheimer's disease","volume":"16","author":"NL Foster","year":"1984","journal-title":"Ann Neurol"},{"key":"58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00003072-200307000-00006","article-title":"A metabolic imaging severity rating scale for the assessment of cognitive impairment","volume":"28","author":"A Newberg","year":"2003","journal-title":"Clin Nuclear Med"},{"key":"59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1176\/appi.neuropsych.15.3.346","article-title":"Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease","volume":"15","author":"OL Lopez","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"60","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1176\/appi.ajp.162.11.1996","article-title":"Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia","volume":"162","author":"G Livingston","year":"2005","journal-title":"Am J Psychiatry"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T17:21:00Z","timestamp":1563384060000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2013\/00000028\/00000007\/art00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7,1]]}},"alternative-id":["8822285608643278"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2013.443","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}